uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities climb as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| UNIQURE (NASDAQ: QURE) | Delayed: 21.63 -0.8 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.43 | 52 Week High | $22.79 | |||
| Open | $22.50 | 52 Week Low | $6.63 | |||
| Day High | $22.61 | P/E | N/A | |||
| Day Low | $21.61 | EPS | $0.00 | |||
| Volume | 660,703 | |||||
